Search Results

Filter
  • 1-10 of  738 results for ""BLOOD coagulation factors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis.

  • Authors : Alwakeal A; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL.; Maas MB

Subjects: Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use ; Thromboembolism*/Thromboembolism*/Thromboembolism*/drug therapy ; Thromboembolism*/Thromboembolism*/Thromboembolism*/prevention & control

  • Source: Critical care medicine [Crit Care Med] 2024 May 01; Vol. 52 (5), pp. 811-820. Date of Electronic Publication: 2024 Feb 14.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0355501 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population.

  • Authors : Sandquist K; Department of Pharmacy, University of New Mexico Hospital, Albuquerque, New Mexico, USA.; Kaucher K

Subjects: Hemostatics*/Hemostatics*/Hemostatics*/therapeutic use ; Thromboembolism*/Thromboembolism*/Thromboembolism*/chemically induced; Adult

  • Source: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

The use of prothrombin complex concentrate in chronic liver disease: A review of the literature.

  • Authors : van Dievoet MA; Laboratory Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Pediatric Hepatology and Cellular Therapy Laboratory, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, 1200, Belgium.

Subjects: Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use ; Thromboembolism*/Thromboembolism*/Thromboembolism*/chemically induced; Humans

  • Source: Transfusion medicine (Oxford, England) [Transfus Med] 2023 Jun; Vol. 33 (3), pp. 205-212. Date of Electronic Publication: 2023 Mar 20.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9301182 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use.

  • Authors : Uttaro E; Department of Pharmacy, University of Rochester Medical Center, 601 Elmwood Ave. Box 638, Rochester, NY 14642, USA. Electronic address: .; Young MR

Subjects: Hemostatics*/Hemostatics*/Hemostatics*/therapeutic use ; Thromboembolism*; Adult

  • Source: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Oct; Vol. 62Publisher: Pergamon Country of Publication: England NLM ID: 101095653 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-0502

Record details

×
Report

Rapid administration of Kcentra® during cardiopulmonary arrest.

  • Authors : White K; Emergency Department, CHRISTUS Mother Frances Hospital, United States of America. Electronic address: .; Gagnon Z

Subjects: Tranexamic Acid*/Tranexamic Acid*/Tranexamic Acid*/therapeutic use ; Thromboembolism* ; Heart Arrest*/Heart Arrest*/Heart Arrest*/chemically induced

  • Source: The American journal of emergency medicine [Am J Emerg Med] 2023 Aug; Vol. 70, pp. 211.e1-211.e3. Date of Electronic Publication: 2023 Feb 14.Publisher: W B Saunders Country of Publication: United States NLM ID: 8309942 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Retrospective Review of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Related Bleedings.

  • Authors : Hitchcock ZR; Pharmacy Department at CoxHealth South National Avenue, Springfield, MO, USA.; Smith SD

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/adverse effects ; Thromboembolism*; Humans

  • Source: Journal of pharmacy practice [J Pharm Pract] 2023 Apr; Vol. 36 (2), pp. 221-226. Date of Electronic Publication: 2021 Jul 07.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study.

  • Authors : Adkins BD; Division of Transfusion Medicine and Hemostasis, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.; Shaim H

Subjects: Off-Label Use* ; Thromboembolism*/Thromboembolism*/Thromboembolism*/chemically induced; Humans

  • Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2023 Jan; Vol. 55 (1), pp. 74-82. Date of Electronic Publication: 2022 Jun 14.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis.

  • Authors : Puchstein D; Department of Anaesthesiology, RWTH Aachen University Hospital, Aachen, Germany.; Kork F

Subjects: Blood Coagulation Disorders*/Blood Coagulation Disorders*/Blood Coagulation Disorders*/chemically induced ; Blood Coagulation Disorders*/Blood Coagulation Disorders*/Blood Coagulation Disorders*/drug therapy ; Thromboembolism*/Thromboembolism*/Thromboembolism*/prevention & control

  • Source: Thrombosis and haemostasis [Thromb Haemost] 2023 Jan; Vol. 123 (1), pp. 40-53. Date of Electronic Publication: 2023 Jan 10.Publisher: Thieme Country of Publication: Germany NLM ID: 7608063 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-689X

Record details

×
Academic Journal

Review of Prothrombin Complex Concentrates Use in Apixaban and Rivaroxaban Associated Intracranial Hemorrhages.

  • Authors : Ibarra F Jr; Community Regional Medical Center, Fresno, CA, USA.

Subjects: Thromboembolism* ; Hemostatics*; Humans

  • Source: Journal of pharmacy practice [J Pharm Pract] 2022 Dec; Vol. 35 (6), pp. 1012-1020. Date of Electronic Publication: 2021 May 26.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series.

  • Authors : Liu J; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Elsamadisi P

Subjects: Factor Xa*/Factor Xa*/Factor Xa*/therapeutic use ; Thromboembolism*/Thromboembolism*/Thromboembolism*/chemically induced ; Thromboembolism*/Thromboembolism*/Thromboembolism*/drug therapy

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Aug 05; Vol. 79 (16), pp. Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  738 results for ""BLOOD coagulation factors""